Seminars in Nephrology
Volume 27, Issue 2 , Pages 195-207 , March 2007

Histopathology of Diabetic Nephropathy

  • Paola Fioretto, MD, PhD

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova Medical School, Padova, Italy
    • Dr. Fioretto was a Juvenile Diabetes Research Foundation Fellow and Career Development Award recipient while performing some of the research reviewed herein.
    • Corresponding Author InformationAddress reprint requests to Paola Fioretto, Department of Medical and Surgical Sciences, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
    • ,
  • Michael Mauer, MD

      Affiliations

    • Pediatric Nephrology, University of Minnesota Medical School, Minneapolis, MN

References 

  1. Mauer M, Fioretto P, Woredekal Y, et al. Diabetic nephropathy. In:  Schrier RW editors. Disease of the kidney and urinary tract. Philadelphia: Lippincott Williams and Wilkins; 2001;p. 2083–2127
  2. Bell ET. Renal vascular disease in diabetes mellitus. Diabetes. 1953;2:376–389
  3. Brito P, Fioretto P, Drummund K, et al. Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int. 1998;53:754–761
  4. Lane PH, Steffes MW, Fioretto P, et al. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int. 1993;43:661–667
  5. Harris RD, Steffes MW, Bilous RW, et al. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin-dependent diabetes. Kidney Int. 1991;40:107–114
  6. Østerby R. Early phases in the development of diabetic glomerulopathy. Acta Med Scand. 1975;475:1–7
  7. Østerby R. Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes I (Development of initial basement membrane thickening). Diabetologia. 1972;8:84–92
  8. Fioretto P, Steffes MW, Mauer SM. Glomerular structure in non-proteinuric insulin-dependent diabetic patients with various levels of albuminuria. Diabetes. 1994;43:1358–1364
  9. Mauer SM, Steffes MW, Ellis EN, et al. Structural functional relationships in diabetic nephropathy. J Clin Invest. 1984;74:1143–1155
  10. Østerby R, Andersen AR, Gundersen HJ. Quantitative studies of glomerular ultrastructure in type 1 diabetics with incipient nephropathy. Diabet Nephropathy. 1984;3:95
  11. Fioretto P, Steffes MW, Sutherland DER, et al. Sequential renal biopsies in IDDM patients: structural factors associated with clinical progression. Kidney Int. 1995;48:1929–1935
  12. Falk RJ, Scheinman JL, Mauer SM, et al. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes. 1983;32:34
  13. Kim Y, Kleppel MM, Butkowski R, et al. Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol. 1991;138:413
  14. Katz A, Caramori ML, Sisson-Ross S, et al. An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int. 2002;61:2058–2066
  15. Najafian B, Kim Y, Crosson JT, et al. Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol. 2003;14:908–917
  16. Najafian B, Crosson JT, Kim Y, et al. Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol. 2006;17:S53–S60
  17. Caramori ML, Kim Y, Huang C, et al. Cellular basis of diabetic nephropathy: 1 (Study design and renal structural-functional relationships in patients with long-standing diabetes). Diabetes. 2002;51:506–513
  18. Bader R, Bader H, Grund KE, et al. Structure and function of the kidney in diabetic glomerulosclerosis (Correlations between morphological and functional parameters). Pathol Res Pract. 1980;167:204–216
  19. Parving H-H, Gall M-A, Skøtt P, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 1992;41:758–762
  20. Lipkin GW. More than one kind of type 2 diabetes with renal disease do not have diabetic nephropathy. J Am Soc Nephrol. 1994;5:37
  21. Gambara V, Mecca G, Remuzzi G, et al. Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol. 1993;3:1458–1466
  22. Ruggenenti P, Gambara V, Perna A, et al. The nephropathy of non-insulin dependent diabetes: predictors of outcome relative to diverse patters of renal injury. J Am Soc Nephrol. 1998;9:2336–2343
  23. Olsen S, Mogensen CE. Non-diabetic renal disease in NIDDM proteinuric patients may be rare in biopsies from clinical practice. Diabetologia. 1996;39:1638–1645
  24. Mazzucco G, Bertani T, Fortunato M. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis. 2002;39:713–720
  25. Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in type 2 (non-insulin dependent) diabetic patients with microalbuminuria. Diabetologia. 1996;39:1569–1576
  26. Najafian B, Caramori ML, Mauer M, et al. Clustering of type 1 and type 2 diabetic patients based on diabetic nephropathy structural-functional relationships. [abstract] J Am Soc Nephrol. 2005;16:679A
  27. Nosadini R, Velussi M, Brocco E, et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes. 2000;49:476–484
  28. Ellis EN, Steffes MW, Goetz FC, et al. Glomerular filtration surface in type 1 diabetes mellitus. Kidney Int. 1986;29:889
  29. Chavers BM, Bilous RW, Ellis EN, et al. Glomerular lesions and urinary albumin excretion rate in type 1 diabetic patients without overt proteinuria. N Engl J Med. 1989;320:966–970
  30. Mauer SM, Sutherland DER, Steffes MW. Relationships of systemic blood pressure to nephropathy in insulin-dependent diabetes mellitus. Kidney Int. 1992;41:736
  31. Bangstad HJ, Østerby R, Hartmann A, et al. Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria. Diabetes Care. 1999;22:314–319
  32. Steinke JM, Sinaiko AR, Kramer MS, et al. International Diabetic Nephropathy Study Group The early natural history of nephropathy in type 1 diabetes (III. Predictors of five-year urinary albumin excretion rate patterns in initially normoalbuminuric patients). Diabetes. 2005;54:2164–2171
  33. Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52:1036–1040
  34. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, et al. Normoalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care. 2004;27:195–200
  35. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type 2 diabetes. J Clin Invest. 1997;99:342–348
  36. Hayashi H, Karasawa R, Inn H, et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int. 1992;41:749–757
  37. Østerby R, Gall MA, Schmitz A, et al. Glomerular structure and function in proteinuric type 2 (non-insulin dependent) diabetic patients. Diabetologia. 1993;36:1064–1070
  38. Lewis EJ, Hunsicker LG, Clarke WR, et al. Collaborative study group Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–860
  39. Brenner BM, Cooper ME, de Zeeuw D, et al. RENAAL study investigators Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869
  40. Lewis EJ, Hunsicker LG, Bain RP, et al. The collaborative study group The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–1462
  41. Kalluri R. Proteinuria with and without renal glomerular podocyte effacement. J Am Soc Nephrol. 2006;17:2383–2389
  42. Barisoni L, Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol. 2003;23:353–360
  43. Kriz W, Gretz N, Lemley KV. Progression of glomerular disease: is the podocyte the culprit?. Kidney Int. 1998;54:687–697
  44. Toyoda M, Najafian B, Groppoli T, et al. Podocyte detachment is associated with less fenestration in glomerular endothelial cells in type 1 diabetes mellitus. [abstract] J Am Soc Nephrol. 2004;15:265A
  45. Ellis EN, Steffes MW, Chavers BM, et al. Observation of glomerular epithelial cell structure in patients with type I diabetes mellitus. Kidney Int. 1987;32:736–741
  46. Bjorn SF, Bangstad H-J, Hanssen KF, et al. Glomerular epithelial foot process and filtration slits in IDDM patients. Diabetologia. 1995;38:1197–1204
  47. Torbjornsdotter TB, Perrin NE, Jaremko GA, et al. Widening of foot processes in normoalbuminuric adolescents with type 1 diabetes. Pediatr Nephrol. 2005;20:750–758
  48. White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes. 2002;51:3083–3089
  49. Steffes MW, Schmidt D, McCrery R, et al. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001;59:2104–2113
  50. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia. 1999;42:1341–1344
  51. Dalla Vestra M, Masiero A, Roiter AM, et al. Is podocyte injury relevant in diabetic nephropathy? (Studies in patients with type 2 diabetes). Diabetes. 2003;52:1031–1035
  52. Steffes MW, Sutherland DER, Goetz FC, et al. Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus. N Engl J Med. 1985;312:1282–1287
  53. Mauer SM, Goetz FC, McHugh LE, et al. Long-term study of normal kidneys transplanted into patients with type I diabetes. Diabetes. 1989;38:516–523
  54. Bilous RW, Mauer SM, Sutherland DER, et al. Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes. 1989;38:1142–1147
  55. Bendtsen TF, Nyengaard JR. The number of glomeruli in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1992;35:844–850
  56. Luyckx VA, Brenner BM. Low birth weight, nephron number and kidney disease. Kidney Int. 2005;97(Suppl):S68–S77
  57. Seaquist ER, Goetz FC, Rich S, et al. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161–1165
  58. Borch-Johnsen K, Norgaard K, Hommel E, et al. Is diabetic nephropathy an inherited complication?. Kidney Int. 1992;41:719–722
  59. Quinn M, Angelico MC, Warram JH, et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940–945
  60. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis. 1995;5:710–713
  61. Pettitt DJ, Saad MF, Bennett PH, et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:438–443
  62. Fioretto P, Steffes MW, Rich SS, et al. Is diabetic nephropathy inherited? (Studies of glomerular structure in type 1 diabetic sibling pairs). Diabetes. 1999;48:865–869
  63. Trevisan R, Viberti G. Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy. Nephrol Dial Transplant. 1997;12:643–645
  64. Trevisan R, Fioretto P, Barbosa J, et al. Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int. 1999;55:2383–2389
  65. Caramori MLA, Mauer M. Pathophysiology of renal complications. In:  Porte D,  Sherwin RS,  Baron A editor. Ellenberg and Rifkin’s Diabetes Mellitus. 6th ed. New York: McGraw-Hill; 2003;p. 697–722
  66. Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 1998;41:47–53
  67. Solini A, Dalla Vestra M, Saller A, et al. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes. 2002;51:251–255
  68. De Cosmo S, Trevisan R, Dalla Vestra M, et al. PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates. Diabetes Care. 2003;26:2898–2902
  69. Orth SR. Smoking—a renal risk factor. Nephron. 2000;86:12–26
  70. Baggio B, Budakovic A, Dalla Vestra M, et al. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol. 2002;13:2730–2736
  71. Bohman S-O, Tyden G, Wilczek H, et al. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes. 1985;34:306–308
  72. Wilczek HE, Jaremko G, Tyden G, et al. Pancreatic graft protects a simultaneously transplanted kidney from developing diabetic nephropathy: a 1 to 6 year follow-up study. Transplant Proc. 1993;1:1314–1315
  73. Bilous RW, Mauer SM, Sutherland DER, et al. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med. 1989;32:80–85
  74. Fioretto P, Mauer SM, Bilous RW, et al. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet. 1993;342:1193–1196
  75. Fioretto P, Steffes MW, Sutherland DER, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69–75
  76. Fioretto P, Sutherland DER, Najafian B, et al. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int. 2006;69:907–912
  77. Fioretto P, Steffes MW, Mihach MJ, et al. Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients. Kidney Int. 1995;48:489–495
  78. Parving H-H, Mauer M, Ritz E. Diabetic nephropathy. In:  Bremer BM editors. Brenner & Rector’s The Kidney. 7th ed. Philadelphia: Elsevier; 2004;p. 1777–1818

 The natural history studies discussed here also were supported by the Juvenile Diabetes Research Foundation. Many of the other studies reported here were supported by National Institutes of Health grant awards (PO1-DK13083, RO1-DK054638, and RO1-DK51975).

PII: S0270-9295(07)00014-9

doi: 10.1016/j.semnephrol.2007.01.012

Seminars in Nephrology
Volume 27, Issue 2 , Pages 195-207 , March 2007

Article Tools

* Image Usage & Resolution